Effect of Albumin on the Biliary Clearance of Compounds in Sandwich-Cultured Rat Hepatocytes
Authors:
- Kenneth R. BrouwerKBKenneth R. Brouwer
- Gary M. PollackGPGary M. Pollack
- 1 October 2008
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 36 (10) , 2086-2092
Abstract
The purpose of the present study was to evaluate the effects of bovine serum albumin (BSA) and essentially fatty acid-free BSA (BSA-FAF) on the biliary clearance of compounds in sandwich-cultured rat hepatocytes. Unbound fraction, biliary excretion index (BEI), and unbound intrinsic biliary clearance (intrinsic \(\mathrm{Cl}_{\mathrm{biliary}}^{{^\prime}}\) ) were determined for digoxin, pravastatin, and taurocholate in the absence or presence of BSA or BSA-FAF. BSA had little effect on the BEI or intrinsic \(\mathrm{Cl}_{\mathrm{biliary}}^{{^\prime}}\) of these compounds. Surprisingly, BSA-FAF decreased both BEI and intrinsic \(\mathrm{Cl}_{\mathrm{biliary}}^{{^\prime}}\) for digoxin and pravastatin, which represent low and moderately bound compounds, respectively. The BEI and intrinsic \(\mathrm{Cl}_{\mathrm{biliary}}^{{^\prime}}\) of taurocholate, a highly bound compound, were not altered significantly by BSA-FAF. Neither BSA nor BSA-FAF had a discernable effect on the bile canalicular networks based on carboxydichlorofluorescein retention. Neither the addition of physiological concentrations of calcium nor the addition of fatty acids to BSA-FAF was able to restore the BEI or intrinsic \(\mathrm{Cl}_{\mathrm{biliary}}^{{^\prime}}\) of the model compounds to similar values in the absence or presence of BSA. Careful consideration is warranted when selecting the type of BSA for addition to in vitro systems such as sandwich-cultured rat hepatocytes.
Keywords
This publication has 45 references indexed in Scilit:
- The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 ActivitiesDrug Metabolism and Disposition, 2008
- Use of plasma proteins as solubilizing agents in in vitro permeability experiments: Correction for unbound drug concentration using the reciprocal permeability approachJournal of Pharmaceutical Sciences, 2008
- Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo ExtrapolationThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Vascular Binding, Blood Flow, Transporter, and Enzyme Interactions on the Processing of Digoxin in Rat LiverThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liverBritish Journal of Pharmacology, 2005
- Bovine-Serum-Albumin-Containing Receptor Phase Better Predicts Transdermal Absorption Parameters for Lipophilic CompoundsJournal of Investigative Dermatology, 2003
- Clinical Pharmacokinetics of PravastatinClinical Pharmacokinetics, 2000
- Stable Inducible Expression of a Functional Rat Liver Organic Anion Transport Protein in HeLa CellsJournal of Biological Chemistry, 1995
- Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transportBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Epithelial Transport Of Drugs In Cell Culture. I: A Model For Studying The Passive Diffusion Of Drugs Over Intestinal Absorbtive (Caco-2) CellsJournal of Pharmaceutical Sciences, 1990